Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Asis Shrestha

TitleAssistant Professor
InstitutionUniversity of Arkansas for Medical Sciences
DepartmentCOM | Housestaff Residents
Address4301 W Markham
Little Rock AR 72205
ORCID ORCID Icon0000-0003-2411-0514 Additional info
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions. Don't see publications published under other names? Login to add alternative names.
    List All   |   Timeline
    1. Cheema H, Shrestha A, Naqvi S, Muttineni S, Dronavalli S, Alrawabdeh J, Alzu'bi M, Schinke CD, Thanendrarajan S, Shaughnessy JD, Zhan F, Zangari M, van Rhee F, Hadidi SA. Clinical outcomes and risk factors of cytomegalovirus reactivation in teclistamab-treated multiple myeloma patients. Blood Cancer J. 2026 Mar 31; 16(1). PMID: 41916955.
      View in: PubMed
    2. Shrestha M, Dahal S, Shrestha A, McNally P, Shrestha AB, Mackler N. Integrating Gene Expression With Recurrent Mutations Improves Age-Stratified Risk Prediction in Acute Myeloid Leukemia. EJHaem. 2026 Apr; 7(2):e70261. PMID: 41821725.
      View in: PubMed
    3. Shrestha A, Thanendrarajan S, Bag A, Dhakal B, Zangari M, Al-Hadidi S, van Rhee F, D'Souza A, Shah N, Shah MR, Mohan M, Schinke C. The efficacy of teclistamab in patients with multiple myeloma and secondary plasma cell leukemia. Blood Adv. 2025 Oct 14; 9(19):4806-4809. PMID: 40674710.
      View in: PubMed
    4. Mohan M, Szabo A, Cheruvalath H, Clennon A, Bhatlapenumarthi V, Patwari A, Balev M, Bhutani D, Shrestha A, Thanendrarajan S, Dhakal B, Zangari M, Trikannad A, Vellanki S, Al-Hadidi S, Lentzsch S, van Rhee F, Bag A, D'Souza A, Shah N, Chakraborty R, Shah MR, Schinke C. Effect of Intravenous Immunoglobulin (IVIG) Supplementation on infection-free survival in recipients of BCMA-directed bispecific antibody therapy for multiple myeloma. Blood Cancer J. 2025 Apr 23; 15(1):74. PMID: 40268898.
      View in: PubMed
    5. Akhtar OS, Szabo A, Bhatlapenumarthi V, Forsberg M, Balev M, Patwari A, Cheruvalath H, Bhutani D, Thanendrarajan S, Dhakal B, Zangari M, Patel T, Shrestha A, Al-Hadidi S, Cooper D, Lentzsch S, van Rhee F, Shah MR, Bag A, D'Souza A, Schinke C, Chakraborty R, Shah N, Mohan M. Immune prognostic score predicts the risk of infection and survival outcomes in patients with relapsed multiple myeloma treated with bispecific antibodies. Br J Haematol. 2024 Nov; 205(5):1830-1834. PMID: 39192546.
      View in: PubMed
    6. Naqvi S, Shrestha A, Alzubi M, Alrawabdeh J, Thanendrarajan S, Zangari M, van Rhee F, Schinke C, Al Hadidi S. Weight loss and dysgeusia in relapsed/refractory multiple myeloma patients treated with talquetamab. EJHaem. 2024 Aug; 5(4):789-792. PMID: 39157593.
      View in: PubMed
    7. Miller K, Stawderman MS, Niraula S, Babbra R, Neupane N, Shrestha A, Gouli S, Kharel Z, Carey K,A, Mohile N, O’Regan R, Falkson CI, Weiss A, Mgnsuson A, Stanford S, Dhakal A. . Journal of Clinical Oncology. Effect of the timing of recurrence on survival among patients with breast cancer with brain metastasis. 2024; 42(16 suppl):e14005.
      View Publication
    8. Naqvi SM, Shrestha A, Alzubi M, Alrawabdeh J, Thanendrarajan S, Zangari M, van Rhee F, Schinke C, Al Hadidi S. Talquetamab (Tal) therapy in relapsed/refractory (R/R) multiple myeloma (MM): Assessing weight loss and dysgeusia. Journal of Clinical Oncology. 2024.
      View Publication
    9. Shrestha A, Alzubi M, Alrawabdeh J, Schinke C, Thanendrarajan S, Zangari M, van Rhee F, Al Hadidi S. B-cell maturation antigen-based therapies post-talquetamab in relapsed or refractory multiple myeloma. EJHaem. 2024 Jun; 5(3):554-559. PMID: 38895072.
      View in: PubMed
    10. Trikannad AK, Shrestha A, Vellanki S, Cheema HI, Patel TH, Bachu R, Sharma S, Jeffus SK, Thanendrarajan S. Amyloid Light-Chain (AL) Amyloidosis of the Trachea Associated With an Indolent B-cell Neoplasm. Cureus. 2024 Jan; 16(1):e53074. PMID: 38414681.
      View in: PubMed
    11. Shrestha J, Shrestha A, Karki P, Dhakal A. Leptomeningeal Disease as an Initial Presenting Manifestation in Breast Cancer. Cureus. 2021 Nov; 13(11):e19666. PMID: 34956772.
      View in: PubMed
    12. Shrestha A, Bischof E. Crusted Scabies Induced Hypereosinophilic Syndrome. Cureus. 2021 May 23; 13(5):e15201. PMID: 34178521.
      View in: PubMed
    Shrestha's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (19) concept(s)
    _
    Co-Authors Expand Description
    See all (11) people
    _
    Same Department Expand Description
    Search Department